ClinicalTrials.Veeva

Menu

Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation

G

Ghent University Hospital (UZ)

Status and phase

Completed
Phase 2

Conditions

Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation

Treatments

Drug: Administration of an ACE-inhibitor or not

Study type

Interventional

Funder types

Other

Identifiers

NCT00263406
2002/055

Details and patient eligibility

About

Randomisation between postoperative administration of an ACE-inhibitor or not.

Full description

Children that are undergoing elective surgery for the creation of a Fontan circulation will be randomised to postoperative administration of an ACE-inhibitor or not.

Determination of aldosteron, renine and ADH in serum preoperatively and 1h, 12h and 5 days postoperatively.

Sex

All

Ages

1 month to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All consecutive children with a univentricular heart disease undergoing elective surgery for creation of a Fontan circulation
  • Parents have agreed with the study after informed consent

Exclusion criteria

  • Urgent / Emergent surgery
  • Preoperative use of an ACE-inhibitor

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems